中船科技(600072.SH):資產重組事項獲得上交所重組委審核通過
格隆匯7月5日丨中船科技(600072.SH)公佈,公司於2023年7月5日收到上海證券交易所併購重組審核委員會(以下簡稱“上交所重組委”)出具的《上海證券交易所併購重組審核委員會2023年第3次審議會議結果公吿》,上交所重組委對公司提交的擬以發行股份及支付現金購買中國船舶重工集團海裝風電股份有限公司100%股份、中國船舶集團風電發展有限公司88.58%股權、中船海為(新疆)新能源有限公司100%股權、洛陽雙瑞風電葉片有限公司44.64%少數股權、中船重工(武漢)凌久電氣有限公司10%少數股權,並擬募集配套資金(以下簡稱“本次交易”)進行了審議,審議結果為:本次交易符合重組條件和信息披露要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.